Project
GA29145
Automatically Closed · 2017 until 2021
Borovicka Jan, Dora Barbara, Frei Remus, Knellwolf Christina, Semadeni Gian-Marco, Sulz Michael
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2017
End Date
2021
Financing
Industry
Brief description/objective
AN OPEN-LABEL EXTENSION AND SAFETY
MONITORING STUDY OF PATIENTS WITH
MODERATELY TO SEVERELY ACTIVE
CROHN’S DISEASE PREVIOUSLY ENROLLED
IN THE ETROLIZUMAB PHASE III
PROTOCOL GA29144